IVD Australia



The Board of IVD Australia is elected by the membership from among the Corporate Representatives of Member Companies. Board Members are elected for a 2 year term and appoint a Chair, Vice-Chair and Treasurer from among their number to serve a 1 year Term.

Current Office Bearers


Mr Sebastian D’Angelo

General Manager, Laboratory Diagnostics Division, Siemens Healthcare – Australia & New Zealand.

Sebastian has over 30 years’ experience within the Australian IVD industry, having worked as a medical scientist in public pathology laboratories before moving to senior roles at Chiron Diagnostics and Bayer Diagnostics and now at Siemens Healthcare Diagnostics.

Sebastian holds a Bachelor of Applied Science (MLS) degree from RMIT University and a Master of Marketing degree from the Melbourne Business School. He is a Member of the Australian Institute of Company Directors.


Paul_Cray_Small.jpgMr Paul Cray

Managing Director of Roche Diagnostics Australia Pty. Ltd. and Leadership Team member of Roche Diagnostics Asia Pacific.

Paul has over 25 years experience in the in vitro diagnostics industry, undertaking numerous overseas roles with increasing sales, marketing strategy and general management responsibility in the UK, Canada, USA, Switzerland and Germany. The most recent post was that of Senior Vice President, Global Marketing, Roche Diagnostics.

Paul holds a Bachelor of Science degree from University College of Wales, UK, and has undertaken numerous post graduate and executive courses at INSEAD, France, IMD, Switzerland and more recently Mt Eliza Advanced Management Programme, Melbourne Business School. Paul is a Member of the Australian Institute of Company Directors.

TreasurerVito Trifilo

Mr Vito Trifilo

General Manager, Tecan Australia 

I have over 20 years’ experience in the Life Science and in vitro diagnostic businesses in the Australian and New Zealand markets.  I have had held business development and sales management roles for over 10 years and was an early company representative with AMRAD Pharmacia Biotech during the start-up phase.  My current role is General Manager at Tecan Australia (a position that I have held for over 2 years), with ANZ sales, marketing, legal and regulatory responsibilities.  Tecan is a leading global provider of laboratory instruments and solutions (strongly automation focussed) in biopharmaceuticals, forensics and clinical diagnostics.



Mr John Crothers

Regional Director, Abbott Diagnostics Pty Ltd.

John Crothers is the Regional Director for Australia and New Zealand. Prior to the role in Australia, John was the Commercial Director for Asia Pacific and has also had several years in US Marketing. With over 25 years’ experience in the pathology industry in both the laboratory and IVD, the appreciation of the value of the industry in healthcare is a passion that John continues to pursue.

John has a BSc(MLS) from RMIT and a Graduate Diploma in Business Administration from Swinburne University. 



Mr Peter Lowe

National Sales Manager and Director of Scientific Affairs, Molecular Diagnostics, ANZ Hologic

My current position is as the National Sales Manager and Director of Scientific Affairs, Molecular Diagnostics, ANZ with Hologic Australia. I have been with Gen-Probe / Hologic since 2011. My role previously was with Silliker Australia as the National Operations Director. I have been part of the medical industry for 30+ years within various private laboratory groups. The latter years included regulatory and quality responsibilities.

1tedm.jpgMr Ted Maione

General Manager, Werfen

Ted is the General Manager of Werfen in Australia, moving from the Boston area of United States three years ago. 

Ted's career in the IVD industry has spanned the last thirty years, the first twenty of which were with Abbott Diagnostics and the last ten years have been with Werfen/IL.  During the twenty years at Abbott he held eight positions of greater responsibility in five different cities throughout the United States. Ten years ago Ted was recruited by Werfen/IL to be the Director of Global Marketing, where his team are responsible for product development and marketing IL’s critical care products throughout the world. 

Ted holds degrees in economics from Rutgers University.

1tedmaione.jpgMr Rayden Rivett

General Manager, Cepheid Holdings Pty Ltd

Rayden has been continuously involved in the IVD Industry since 1979 working in sales, marketing and senior management. For 15 years he was Managing Director of bioMérieux in Australia and since 2006 has worked in the USA, Asia-Pacific and more recently in establishing Australian subsidiaries for overseas-based IVD companies. Rayden has represented the IVD sector in the past, being a Board member of MIAA (now MTAA) from 1999 to 2006 and its Vice-Chair (2003-2004), a member of their Diagnostic/IVD Standing Committee 1994-2001, member of the Market Development Committee (1997-2003) and its Chair (2000-2002).

Mark_Volling.jpgMr Mark Volling

Regional Managing Director for Alere in Australia and New Zealand.

I possess over 25 years’ experience within the Australian IVD industry including senior roles within global companies, local manufacturing/export companies  and distributor only organisations. The breadth of my experience includes extensive M&A within our industry sector and other healthcare segments.  I possess an Associate Diploma in Clinical Laboratory Techniques (QUT), Bachelor Business in Finance/Accounting (USQ), Graduate Certificate in Management in International Business (USQ) and a Masters of Technology/Innovation Management (UQ).